The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IMW 2019 | Off the shelf NK-cell MM therapy
Sarah Holstein
• 14 Sep 2019
Sarah Holstein, MD, PhD, University of Nebraska Medical Center, Omaha, NE, elaborates on placental derived natural killer (NK) cells (PNK007) and their integration into the post-melphalan transplantation period of multiple myeloma (MM). Dr Holstein goes on to lay out the next steps for PNK-cell therapy. This interview was recorded at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.
